Relapsed or Refractory Lymphoma Including ENKL Clinical Trials in Shanghai, Shangai

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL